Clearstead Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $625K | Sell |
16,280
-26
| -0.2% | -$998 | 0.01% | 552 |
|
|
2025
Q1 | $632K | Sell |
16,306
-901
| -5% | -$34.9K | 0.01% | 522 |
|
|
2024
Q4 | $582K | Sell |
17,207
-665
| -4% | -$22.5K | 0.01% | 535 |
|
|
2024
Q3 | $731K | Sell |
17,872
-559
| -3% | -$22.9K | 0.01% | 486 |
|
|
2024
Q2 | $710K | Buy |
18,431
+10,925
| +146% | +$421K | 0.01% | 468 |
|
|
2024
Q1 | $339K | Sell |
7,506
-168
| -2% | -$7.59K | 0.02% | 381 |
|
|
2023
Q4 | $284K | Sell |
7,674
-8,292
| -52% | -$307K | 0.02% | 406 |
|
|
2023
Q3 | $579K | Buy |
15,966
+7,978
| +100% | +$289K | 0.02% | 387 |
|
|
2023
Q2 | $285K | Buy |
7,988
+1,818
| +29% | +$64.8K | 0.02% | 382 |
|
|
2023
Q1 | $220K | Buy |
6,170
+2,575
| +72% | +$91.6K | 0.02% | 377 |
|
|
2022
Q4 | $126K | Sell |
3,595
-609
| -14% | -$21.4K | 0.01% | 455 |
|
|
2022
Q3 | $124K | Sell |
4,204
-1,126
| -21% | -$33.2K | 0.01% | 432 |
|
|
2022
Q2 | $290K | Buy |
5,330
+1,389
| +35% | +$75.6K | 0.02% | 324 |
|
|
2022
Q1 | $215K | Buy |
3,941
+311
| +9% | +$17K | 0.01% | 392 |
|
|
2021
Q4 | $200K | Sell |
3,630
-3,136
| -46% | -$173K | 0.01% | 387 |
|
|
2021
Q3 | $323K | Buy |
6,766
+1,267
| +23% | +$60.5K | 0.02% | 300 |
|
|
2021
Q2 | $274K | Buy |
5,499
+3,353
| +156% | +$167K | 0.02% | 304 |
|
|
2021
Q1 | $96K | Buy |
2,146
+220
| +11% | +$9.84K | 0.01% | 446 |
|
|
2020
Q4 | $89K | Buy |
1,926
+172
| +10% | +$7.95K | 0.01% | 438 |
|
|
2020
Q3 | $83K | Sell |
1,754
-1,949
| -53% | -$92.2K | 0.01% | 395 |
|
|
2020
Q2 | $189K | Hold |
3,703
| – | – | 0.02% | 272 |
|
|
2020
Q1 | $175K | Sell |
3,703
-515
| -12% | -$24.3K | 0.03% | 252 |
|
|
2019
Q4 | $248K | Buy |
+4,218
| New | +$248K | 0.03% | 246 |
|